Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Sitemap: http://attralus.com/sitemap_index.xml User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Disallow: *.pdf$ # Block pdf files from all bots. Albeit non-standard, it works for major search |
Title | Novel Pan-Amyloid Removal (PAR) Therapeutics | |
Description | BRINGING NEW Our mission is to improve the lives of amyloidosis patients by developing transformational therapeutics focused on amyloid |
Keywords | N/A |
WebSite | attralus.com |
Host IP | 99.83.190.102 |
Location | United States |
Site | Rank |
US$7,321,013
Last updated: 2023-05-02 08:21:55
attralus.com has Semrush global rank of 1,445,743. attralus.com has an estimated worth of US$ 7,321,013, based on its estimated Ads revenue. attralus.com receives approximately 844,733 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, attralus.com is safe to visit. |
Purchase/Sale Value | US$7,321,013 |
Daily Ads Revenue | US$6,758 |
Monthly Ads Revenue | US$202,736 |
Yearly Ads Revenue | US$2,432,829 |
Daily Unique Visitors | 56,316 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
attralus.com. | A | 600 | IP: 99.83.190.102 |
attralus.com. | A | 600 | IP: 75.2.70.75 |
attralus.com. | NS | 3600 | NS Record: ns68.domaincontrol.com. |
attralus.com. | NS | 3600 | NS Record: ns67.domaincontrol.com. |
attralus.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
attralus.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
attralus.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
attralus.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
attralus.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
attralus.com. | TXT | 600 | TXT Record: google-site-verification=1p6eI2JyMfYFIlYnaT0zVz2sJP-5uTDEQ_gb2xzWyUQ |
attralus.com. | TXT | 600 | TXT Record: v=verifydomain MS=7425740 |
attralus.com. | TXT | 600 | TXT Record: v=spf1 include:dc-aa8e722993._spfm.attralus.com include:spf.protection.outlook.com ~all |
attralus.com. | TXT | 600 | TXT Record: google-site-verification=do2Q14yKuMkwkkDdZmYDWDHcclLnrIt38pC1242y92o |
attralus.com. | TXT | 600 | TXT Record: docusign=32f3e61a-be72-4e23-9a72-b36813293b8f |
Home Company About Management Team Board of Directors Scientific Advisory Board Investors Science Approach Pan-Amyloid Removal (PAR) Pan-Amyloid Diagnostic Pipeline News Press Releases Posters & Publications In the News Amyloidosis Careers Contact Home Company About Management Team Board of Directors Scientific Advisory Board Investors Science Approach Pan-Amyloid Removal (PAR) Pan-Amyloid Diagnostic Pipeline News Press Releases Posters & Publications In the News Amyloidosis Careers Contact BRINGING NEW POSSIBILITIES TO SYSTEMIC AMYLOIDOSIS Attralus is developing novel pan-amyloid removal (PAR) therapeutics that directly bind to and remove toxic amyloid, opening the potential to treat and reverse disease in all types of systemic amyloidosis. Amyloid Removal Patient Diagnosis All Disease Types UNMET MEDICAL NEEDS PATIENTS ARE IN NEED OF NEW TREATMENT OPTIONS Systemic amyloidosis includes a diverse group of debilitating, progressive, and often fatal diseases, characterized by the |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Sun, 24 Oct 2021 19:31:37 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://attralus.com/ HTTP/2 301 server: openresty date: Sun, 24 Oct 2021 19:31:37 GMT content-type: text/html content-length: 166 location: https://www.attralus.com/ HTTP/2 200 server: openresty date: Sun, 24 Oct 2021 19:31:37 GMT content-type: text/html content-length: 39185 content-security-policy: frame-ancestors 'self' x-frame-options: SAMEORIGIN x-lambda-id: b0493cd8-1ad6-4873-ba20-fe5a02231e45 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 26873 x-served-by: cache-dca17744-DCA, cache-wdc5538-WDC x-cache: MISS, HIT x-cache-hits: 0, 1 x-timer: S1635103898.743311,VS0,VE2 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
Domain Name: ATTRALUS.COM Registry Domain ID: 2542700857_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-06-30T02:16:49Z Creation Date: 2020-06-30T02:16:48Z Registry Expiry Date: 2022-06-30T02:16:48Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS67.DOMAINCONTROL.COM Name Server: NS68.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T01:41:13Z <<< |